We are live on ! Find out more
Royal Bank of Canada

Royal Bank of Canada Portfolio holdings

AUM $672B
1-Year Est. Return 33.48%
 

Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.

This Fund
S&P 500
This Quarter Est. Return
+5.11%
1 Year Est. Return
+33.48%
3 Year Est. Return
+94.84%
5 Year Est. Return
+111.06%
10 Year Est. Return
+380.55%
AUM
$241B
AUM Growth
+$18B
Cap. Flow
+$7.98B
Cap. Flow %
3.32%
Top 10 Hldgs %
19.68%
Holding
7,300
New
581
Increased
3,668
Reduced
2,038
Closed
278

Sector Composition

Rank Sector Weight
1 Financials 21.28%
2 Energy 8.55%
3 Technology 8.33%
4 Industrials 8.04%
5 Healthcare 6.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PAGS icon
5426
PagSeguro Digital
PAGS
$2.4B
$30K ﹤0.01%
1,073
+823
+329% +$22.4K
SCOR icon
5427
Comscore
SCOR
$93.6M
$30K ﹤0.01%
81
SHYL icon
5428
Xtrackers Short Duration High Yield Bond ETF
SHYL
$267M
$30K ﹤0.01%
+600
New +$29.7K
AIVC
5429
Amplify Bloomberg AI Equal Weight ETF
AIVC
$127M
$30K ﹤0.01%
783
-500
-39% -$18.3K
KDNY
5430
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$30K ﹤0.01%
805
+36
+5% +$1.16K
ACOR
5431
DELISTED
Acorda Therapeutics
ACOR
$30K ﹤0.01%
13
+10
+333% +$31K
FSTX
5432
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$30K ﹤0.01%
627
+78
+14% +$3.91K
XOG
5433
DELISTED
Extraction Oil & Gas, Inc. Common Stock
XOG
$30K ﹤0.01%
2,659
-5,541
-68% -$70.4K
SVBI
5434
DELISTED
Severn Bancorp Inc/MD
SVBI
$30K ﹤0.01%
3,065
+24
+0.8% +$214
PGNX
5435
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$30K ﹤0.01%
4,530
+914
+25% +$7.02K
ESGW
5436
DELISTED
Columbia Sustainable Global Equity Income ETF
ESGW
$30K ﹤0.01%
1,003
+217
+28% +$6.49K
EGL
5437
DELISTED
Engility Holdings, Inc.
EGL
$30K ﹤0.01%
869
-1,937
-69% -$66.7K
ADMA icon
5438
ADMA Biologics
ADMA
$2.12B
$29K ﹤0.01%
4,628
+593
+15% +$3.42K
AXTA icon
5439
PUT
Axalta
AXTA
$7.99B
$29K ﹤0.01%
1,000
-150,000
-99% -$4.5M
CLW icon
5440
Clearwater Paper
CLW
$345M
$29K ﹤0.01%
967
+81
+9% +$2.18K
CWK icon
5441
Cushman & Wakefield Ltd
CWK
$3.38B
$29K ﹤0.01%
+1,698
New +$30.3K
DALN
5442
DELISTED
DallasNews
DALN
$29K ﹤0.01%
1,582
+13
+0.8% +$233
ENTA icon
5443
Enanta Pharmaceuticals
ENTA
$383M
$29K ﹤0.01%
344
-2,230
-87% -$223K
FLN icon
5444
First Trust Latin America AlphaDEX Fund
FLN
$35.5M
$29K ﹤0.01%
1,536
GAIA icon
5445
Gaia
GAIA
$37.1M
$29K ﹤0.01%
1,895
+185
+11% +$3.32K
GPRE icon
5446
Green Plains
GPRE
$1.09B
$29K ﹤0.01%
1,652
+783
+90% +$13.4K
JPXN
5447
iShares JPX-Nikkei 400 ETF
JPXN
$142M
$29K ﹤0.01%
451
+221
+96% +$13.9K
MGRC icon
5448
McGrath RentCorp
MGRC
$2.99B
$29K ﹤0.01%
536
-9,835
-95% -$573K
MTR
5449
Mesa Royalty Trust
MTR
$5.39M
$29K ﹤0.01%
2,000
OFIX icon
5450
Orthofix Medical
OFIX
$421M
$29K ﹤0.01%
509
+170
+50% +$9.53K

Similar funds

Royal Bank of Canada's Q3 2018 Portfolio in Review

As of Q3 2018, Royal Bank of Canada held 7,300 positions worth $241B, up 8.1% from $223B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Royal Bank of Canada deployed $7.98B of net new capital in Q3 2018, opening 581 new positions and adding to 3,668 existing holdings. Its largest new stake was Bombardier Recreational Products: 459,399 shares worth $21.7M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 22% a quarter earlier, followed by Energy and Technology.

On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $518M trimmed.

  • Royal Bank of Canada's largest Q3 2018 buy was Bombardier Recreational Products: 459,399 shares worth $21.7M.
  • Royal Bank of Canada added most to Vanguard Intermediate-Term Corporate Bond ETF in Q3 2018, an estimated $261M increase.
  • Royal Bank of Canada's biggest Q3 2018 reduction was iShares Core S&P 500 ETF, cutting an estimated $518M.
  • Royal Bank of Canada fully exited Validus Hold Ltd in Q3 2018, selling an estimated $31.8M.
  • Royal Bank of Canada's ten largest holdings make up 20% of its $241B portfolio in Q3 2018.
  • Royal Bank of Canada opened 581 new positions and closed 278 in Q3 2018.
  • Royal Bank of Canada's portfolio value rose 8.1% quarter-over-quarter to $241B.

Based on Royal Bank of Canada's 13F filing for Q3 2018, filed 14 Nov 2018.